Geode Capital Management
EXAS

Geode Capital Management’s Exact Sciences EXAS Stock Holding History

Geode Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,331,580
Closed -$338M – 4547
2025
Q4 		$338M Buy
3,331,580
+19,753
+0.6% +$1.59M 0.02% 539
2025
Q3 		$181M Buy
3,311,827
+74,787
+2% +$3.74M 0.01% 737
2025
Q2 		$172M Sell
3,237,040
-29,399
-0.9% -$1.49M 0.01% 731
2025
Q1 		$141M Buy
3,266,439
+143,641
+5% +$7.27M 0.01% 778
2024
Q4 		$175M Buy
3,122,798
+16,828
+0.5% +$1.05M 0.01% 685
2024
Q3 		$211M Buy
3,105,970
+7,873
+0.3% +$444K 0.02% 616
2024
Q2 		$131M Buy
3,098,097
+128,207
+4% +$7.05M 0.01% 766
2024
Q1 		$205M Buy
2,969,890
+89,628
+3% +$5.67M 0.02% 583
2023
Q4 		$213M Buy
2,880,262
+111,911
+4% +$7.34M 0.02% 544
2023
Q3 		$189M Buy
2,768,351
+72,311
+3% +$6.14M 0.02% 544
2023
Q2 		$253M Buy
2,696,040
+104,983
+4% +$8.19M 0.03% 475
2023
Q1 		$175M Buy
2,591,057
+91,883
+4% +$5.91M 0.02% 545
2022
Q4 		$124M Buy
2,499,174
+126,538
+5% +$5.17M 0.02% 628
2022
Q3 		$77M Buy
2,372,636
+23,903
+1% +$985K 0.01% 802
2022
Q2 		$92.4M Buy
2,348,733
+84,500
+4% +$4.52M 0.01% 718
2022
Q1 		$158M Buy
2,264,233
+92,267
+4% +$6.74M 0.02% 602
2021
Q4 		$169M Buy
2,171,966
+76,790
+4% +$6.78M 0.02% 592
2021
Q3 		$200M Buy
2,095,176
+1,545
+0.1% +$163K 0.03% 530
2021
Q2 		$260M Buy
2,093,631
+153,054
+8% +$18.3M 0.04% 446
2021
Q1 		$255M Buy
1,940,577
+209,172
+12% +$28.6M 0.04% 431
2020
Q4 		$229M Buy
1,731,405
+151,055
+10% +$18.3M 0.04% 422
2020
Q3 		$161M Sell
1,580,350
-4,876
-0.3% -$421K 0.03% 461
2020
Q2 		$138M Sell
1,585,226
-20,183
-1% -$1.61M 0.03% 474
2020
Q1 		$93M Buy
1,605,409
+33,528
+2% +$2.72M 0.02% 520
2019
Q4 		$145M Buy
1,571,881
+186,817
+13% +$16.4M 0.03% 495
2019
Q3 		$125M Buy
1,385,064
+35,143
+3% +$4M 0.03% 499
2019
Q2 		$159M Buy
1,349,921
+71,590
+6% +$7.21M 0.04% 431
2019
Q1 		$111M Buy
1,278,331
+80,491
+7% +$6.85M 0.03% 521
2018
Q4 		$75.6M Buy
1,197,840
+69,128
+6% +$4.74M 0.02% 568
2018
Q3 		$89.1M Buy
1,128,712
+13,642
+1% +$890K 0.03% 566
2018
Q2 		$66.7M Sell
1,115,070
-10,946
-1% -$589K 0.02% 638
2018
Q1 		$45.4M Buy
1,126,016
+27,376
+2% +$1.34M 0.01% 779
2017
Q4 		$57.7M Buy
1,098,640
+24,614
+2% +$1.31M 0.02% 650
2017
Q3 		$50.6M Buy
1,074,026
+9,810
+0.9% +$395K 0.02% 671
2017
Q2 		$37.6M Buy
1,064,216
+122,419
+13% +$3.78M 0.01% 790
2017
Q1 		$22.2M Buy
941,797
+106,536
+13% +$2.11M 0.01% 1059
2016
Q4 		$11.2M Buy
835,261
+45,689
+6% +$738K 0.01% 1497
2016
Q3 		$14.7M Buy
789,572
+87,282
+12% +$1.54M 0.01% 1219
2016
Q2 		$8.6M Buy
702,290
+53,770
+8% +$405K ﹤0.01% 1549
2016
Q1 		$4.37K Buy
648,520
+28,116
+5% +$180K ﹤0.01% 1956
2015
Q4 		$5.73M Sell
620,404
-10,517
-2% -$97.8K ﹤0.01% 1783
2015
Q3 		$11.3M Buy
630,921
+49,833
+9% +$1.14M 0.01% 1253
2015
Q2 		$17.3M Buy
581,088
+16,411
+3% +$412K 0.01% 1020
2015
Q1 		$12.4M Buy
564,677
+48,832
+9% +$1.24M 0.01% 1219
2014
Q4 		$14.2M Buy
515,845
+19,265
+4% +$469K 0.01% 1077
2014
Q3 		$9.62M Buy
496,580
+4,296
+0.9% +$78.8K 0.01% 1281
2014
Q2 		$8.38M Buy
492,284
+102,092
+26% +$1.41M 0.01% 1439
2014
Q1 		$5.53M Buy
390,192
+13,166
+3% +$178K ﹤0.01% 1700
2013
Q4 		$4.41M Buy
377,026
+53,069
+16% +$609K ﹤0.01% 1797
2013
Q3 		$3.83M Buy
323,957
+61,318
+23% +$787K ﹤0.01% 1755
2013
Q2 		$3.65M Buy
+262,639
New +$2.85M ﹤0.01% 1644

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Geode Capital Management's EXAS Position: Q1 2026 in Review

Geode Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,331,580 shares — an estimated $338M sold.

Geode Capital Management first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $338M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Geode Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Geode Capital Management sold 3,331,580 Exact Sciences shares in Q1 2026, an estimated $338M.
  • Geode Capital Management first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Geode Capital Management's Exact Sciences position peaked at $338M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.